| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |